Invest in ME Research
IiME UK RITUXIMAB CLINICAL TRIAL and B-Cell Research
Energising Biomedical Research into ME - Mainstreaming ME Research
Clinical Trials for ME
Let's Do It For ME - Let's Do Research


 

 

LINKS and REFERENCES

 

REFERENCES

R1

 

  Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study    
     
R2

 

  B-lymphocyte depletion with Rituximab induction and maintenance in CFS/ME. A multicenter, randomized, double blind, placebo-controlled study   

 

R3   6th Invest in ME International ME/CFS Conference 2011 The Way Forward for ME - A Case for Clinical Trials     

 

R4   Biomedical Research into ME Collaborative Meeting (BRMEC) Crowdsourcing for ME

   

R5   8th Invest in ME International ME (ME/CFS) Conference 2013 Infection, Immunity and Myalgic Encephalomyelitis - Mainstreaming ME Research

 

R6   Invest in ME proposal for an examination and research facility for ME

 

R7   IiME Foundation project for examination and research facility for ME
 
R8

 

  Bradley, A. S., Ford, B. and Bansal, A. S. (2013), Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clinical & Experimental Immunology, 172: 7380. doi: 10.1111/cei.12043 http://onlinelibrary.wiley.com/doi/10.1111/cei.12043/abstract

 

LINKS

 

Other useful links regarding biomedical research into ME.